In addition, to further increase efficacy and limit side effects, we are also exploring the bi-specific antibody strategy to retarget the Ad-PEDF adenovirus to melanoma tumor tissue, as Reynolds et al prepared a targetable adenovirus-mediated gene transfer to pulmonary endothelium [33,34]. This evidence concerns the gene SERPINF1 and melanoma.